Sign in
Taking people in United StatesPhase 3

Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3

Key facts

Who runs it
Emory University
Where
Atlanta, United StatesSee the 6 sites
Trial code
Status
Recruiting
Phase
Phase 3
People taking part
103 people, planned
Started
20 Feb 2024
Expected to end
Apr 2027
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Transcutaneous Cervical Vagal Nerve Stimulation
  • Sham Stimulation
  • [F-18]Fallypride
Record updated
27 March 2026

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Meet criteria for OUDs based on the DSM5 criteria
  • Willing to undergo supervised withdrawal
  • Willing to be transitioned to a MOUD or behavioral management during treatment aftercare

Who cannot take part

  • Current treatment with methadone, naltrexone, or Suboxone or medications that would be contraindicated with hydromorphone or clonidine administration
  • History of meningitis
  • History of head trauma resulting in loss of consciousness (LOC) of greater than one minute where the LOC is not judged to be primarily related to overdose in the judgment of the study physician
  • Past year moderate to severe non-opioid use disorders that would require separate withdrawal management
  • Current or lifetime history of schizophrenia, schizoaffective disorder, or bulimia
  • History of shrapnel or other foreign bodies that would preclude MRI scanning
  • Positive test for COVID-19
  • History of serious medical or neurological illness or organic mental disorder, including liver disease, but also including cardiovascular, gastrointestinal, hepatic, renal, neurologic, or other systemic illness, including liver enzymes aspartate transaminase (AST) and alanine transaminase (ALT) more than three times upper limit of normal, that would preclude involvement based on the clinical judgment of the study psychiatrist
  • Positive pregnancy test or breastfeeding for women
  • Traumatic brain injury
  • Lack of venous access that would preclude PET imaging
  • Active implantable device (i.e. pacemaker) or other VNS device exclusion

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

This trial is currently available in United States.

  • 12 Executive Park DriveAtlanta, United StatesContact: James D Bremner, MDTaking people
  • Emory UniversityAtlanta, United StatesContact: James D Bremner, MDTaking people
  • Emory University Clinical Research NetworkAtlanta, United StatesContact: James D Bremner, MDTaking people
  • Georgia Institute of TechnologyAtlanta, United StatesContact: James D Bremner, MDTaking people
  • Health Sciences Research BuildingAtlanta, United StatesContact: James D Bremner, MDNot yet recruiting
  • Rollins School of Public HealthAtlanta, United StatesContact: James D Bremner, MDTaking people

About the trial

What the trial wants to find out

This study is being done to answer the question: what is the effect of Vagal Nerve Stimulation (VNS) dosing on opioid withdrawal responses in individuals with a history of Opioid Use Disorders (OUDs)? Eligible participants will be in the study for one week in an inpatient research hospital stay, have an MRI scan, and have a follow-up call 1-3 months after their inpatient stay. Participants will complete several psychiatric questionnaires/interviews, physiological monitoring with several devices, brain imaging, and VNS testing.

The 2 groups in the trial

  • Transcutaneous Cervical Vagal Nerve Stimulation DeviceTreatment being tested

    Stimulation with the tcVNS

    Treatment: Transcutaneous Cervical Vagal Nerve Stimulation and [F-18]Fallypride

  • Sham Stimulation DeviceSham treatment, for comparison

    Stimulation with the sham device.

    Treatment: Sham Stimulation and [F-18]Fallypride

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT05834478, who can take part
Record updated
27 March 2026